Slowing Down Alzheimer’s Disease

Mouse study finds 2 proteins may keep brain plaques from forming

HealthDayNews — Two proteins appear to work together in mice to prevent the formation of the brain plaques that are characteristic of Alzheimer’s disease.

Researchers at Washington University School of Medicine in St. Louis report in the Jan. 22 issue of Neuron that the proteins clusterin and apolipoprotein E (apoE) seem to orchestrate the removal of potentially hazardous molecules from the brain.

Ironically, previous research implicated these same proteins in a key stage of brain plaque formation.

“This is one of the first demonstrations in living animals that these proteins affect amyloid clearance,” Dr. David H. Holtzman, head of the neurology department, says in a prepared statement.

“Our findings suggest it is worthwhile to explore the use of drugs or therapies to alter or perhaps increase the expression of these proteins as a potential treatment for Alzheimer’s disease,” Holtzman says.

—–

On the Net:

Alzheimer’s disease information

Washington University School of Medicine

More science, space, and technology from RedNova

Copyright © 2003 HealthDay. All rights reserved. The information contained above is intended for general reference purposes only. It is not a substitute for professional medical advice or a medical exam. Always seek the advice of your physician or other qualified health professional before starting any new treatment. Medical information changes rapidly and while Yahoo and its content providers make efforts to update the content on the site, some information may be out of date. No health information on Yahoo, including information about herbal therapies and other dietary supplements, is regulated or evaluated by the Food and Drug Administration and therefore the information should not be used to diagnose, treat, cure or prevent any disease without the supervision of a medical doctor.